Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Open Innovation for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
PL Intelligence
Reports
Partnering Consulting
Due Diligence
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Due Diligence
Overview
Top Applications
Online Panel Discussions
Request Consultation
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Corporation
Companies

Aptus Pharmaceuticals

Aptus Pharmaceuticals, Inc. is a drug discovery company that uses its proprietary technologies to develop therapeutics targeting G-Protein Coupled Receptors (GPCRs).

The company in detail

Summary

Aptus Pharmaceuticals is a biotechnology company using proprietary technologies to validate G-protein coupled receptors as drug targets and to develop therapeutics aimed at these receptors.

R&D

To view this information, you must subscribe to PL Intelligence.

Partnerships

To view this information, you must subscribe to PL Intelligence.

Deals

To view this information, you must subscribe to PL Intelligence.

Senior management

To view this information, you must subscribe to PL Intelligence.

Board of directors

To view this information, you must subscribe to PL Intelligence.

Clients in focus...

Get the Flash Player to see this rotator.

Partnering consultation free of charge
The countdown has started...
Stem Cell USA
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us